Background: Many cytokines propose to play a role in the pathogenesis of Severe Acute
Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) associated COVID-19 disease …

This study aimed to evaluate the association of interleukin-6 (IL-6) level with the poor
outcomes in coronavirus disease 2019 (COVID-19) patients by utilizing a meta-analysis …

Abstract Coronavirus disease 2019 (COVID 19) may cause multi-organ involvement due to
viralinduced hyper inflammation. In coronavirus disease‐2019 (COVID19) cases, hyper …

Coronavirus disease 2019 (COVID‐19) has spread rapidly around the world since its
emergence in humans last December. Previous studies suggested that numerous markers …

The investigation is centered on evaluating the impact of interleukin-6 (IL-6) on determining
the seriousness of COVID-19 among individuals in Bangladesh, a nation grappling with …

Background: Patients with COVID-19 have characteristic of hyper inflammation, so the
associated inflammatory biomarkers may be helpful for forecast the severity. But data for …

Abstract Objective The SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19),
leads to severe pathogenicity and high mortality among different communities around the …

Abstract Cytokines, notably interleukin-6 (IL-6), increase considerably in patients with severe
corona virus disease 2019 (COVID-19). This vigorous immune response may cause end …

Background: Robust data on interleukin-6 (IL-6) are available in bacterial infection as
marker of inflammation, and now it can be utilized in currently ongoing coronavirus disease …

COVID-19 has emerged as a global pandemic. It is mainly manifested as pneumonia which
may deteriorate into severe respiratory failure. The major hallmark of the disease is the …